Lpga prohibited substances list

LPGA Prohibited Substance Classes and Prohibited Methods1
The LPGA list of prohibited classes and prohibited methods is subject to change by the LPGA.
The term “related substances and compounds” comprises substances that are included in the
class by their pharmacological action and/or chemical structure. No substance belonging to the
prohibited class may be used at any time, regardless of whether it is specifically listed below as
an example of a substance within that class.
NOTE: Many nutritional and/or dietary supplements may contain LPGA prohibited substances.
In addition, the U.S. Food and Drug Administration (FDA) does not strictly regulate the
supplement industry; therefore, purity and safety of nutritional and/or dietary supplements cannot
be guaranteed. Impure and/or contaminated supplements may lead to a LPGA positive drug test.
The use of nutritional and/or dietary supplements is at the LPGA player’s own risk.

1. Anabolic Agents: Anabolic agents are used as athletic performance enhancers to achieve
increases in muscle mass, strength and speed; to improve recovery from training; and to increase mental aggressiveness. androstenediol , androstenedione, bolandiol, bolasterone, boldenone, boldione,
calusterone, clostebol, danazol, dehydrochlormethyltestosterone, dehydroepiandrosterone
(DHEA), desoxymethyltestosterone, drostanolone, epitrenbolone, ethylestrenol,
fluoxymesterone, formebolone, furazabol, gestrinone, 4-hydroxytesterone, mestanolone,
mesterolone, metenolone, methandienone, methandriol, methasterone, methenolone,
methyldienolone, methyl-1-tetstosterone, methylnortestosterone, methyltestosterone,
metribolone, methyltrienolone, mibolerone, nandrolone, norandrostenedione, 19-
norandrostenedione, norandrostenediol, 19-noretiocholanolone, 19-norandrosterone,
norboletone, norclostebol, norethandrolone, oxabolone, oxandrolone, oxymesterone,
oxymetholone, prostanozol, quinbolone, stanozolol, stenbolone, testosterone, 1-
testosterone, tetrahydrogestrinone (THG), trenbolone; and all related substances and

2. Substances having anabolic properties and/or anabolic effects, including but not
limited to: clenbuterol , tibolone, zeranol, zilpaterol 3. Peptide Hormones, Growth Factors and Related Substances: The following and
their releasing factors are prohibited: erythropoiesis-stimulating agents (e.g.,
erythropoietin (EPO), darbepoetin, dypoxia-inducible factor stabilizers, methoxy
polyethylene glycolepoetin beta, peginesatide; chorionic gonadotrophin and luteinizing
hormone, corticotrophins; growth hormone, insulin-like growth factor, fibroblast growth
factors, mechano growth factors, platelet-derived growth factor, vascular-endothelial
growth factor, and hepatocyte growth factor, as well as any other growth factor affecting
muscle, tendon or ligament protein synthesis/degradation, vascularization, energy
utilization, regenerative capacity or fibre type switching; and all related substances and

1 The LPGA list of prohibited classes and prohibited methods is subject to change by the LPGA.
4. Stimulants: Stimulants are used as athletic performance enhancers to improve
concentration and alertness, increase aggressiveness and to relieve the perception of fatigue during practice and competition. Adrafinil, adrenaline, amfepramone, amiphenazole, amphetaminil, amphetamine,
benfluorex, benzphetamine, benzylpiperazine, bromantan, cathine (5 micrograms per
milliliter), chlorphentermine, clobenzorex, cocaine, cropropamide, crotetamide,
crothetamide, dimethylamphetamine, dimethylamyaline, dimethylamylamine (DMAA),
dimethylpentylamine, fenproporex, furfenorex, heptaminol, ephedrine (ephedra, ma
huang)(greater than 10 micrograms per milliliter), ethamivan, ethylamphetamine,
etilamphetamine, etilefrine, famprofazone, fenbutrazate, fencamfamine, fencamine,
fenetylline, fenfluramine, fenproporex, furfenorex, geranamine, geranium oil,
heptaminol, isometheptene, levmetametamine, meclofenoxate, mefenorex,
mephentermine, mesocarb, methamphetamine, p-methylamphetamine,
methylenedioxyamphetamine, methylenedioxymethamphetamine (MDMA, ectasy),
methylephedrine, methylhexaneamine, methylphenidate, methylsynephrine, modafinil,
nikethamide, norfenefrine, norfenfluramine, octopamine, oxilofrine,
parahydroxyamphetamine, pemoline, pentetrazol, phendimetrazine, phenmetrazine,
phrenpromethamine, phentermine, phenylpropanolamine (ppa), prenylamine, prolintane,
propylhexedrine, p-methylamphetamine, selegiline, sibutramine, strychnine,
tuaminoheptane; and all related substances and compounds
The following stimulants are not prohibited: caffeine, phenylephrine, pseudoephedrine,
5. Beta-Blockers: Beta-blockers work as performance enhancers in sport because they
diminish the effects of adrenaline, the hormone that increases heart rate in times of anxiety or fear. Beta-blockers reduce the heart rate, which in turn creates a calming effect and decreases hand tremors. acebutolol, alprenolol, atenolol, bendroflumethiazide-nadolol, betaxolol, bisoprolol,
bunolol, carteolol, carvedilol, celiprolol, esmolol, labetalol, levobunolol, metipranolol,
metoprolol, nadolol, oxprenolol, pindolol, propranolol, sotalol, timolol; and all related
, and compounds
6. Agents With Anti-Estrogenic Activity: Anti-estrogenic substances serve as masking
agents because they may reduce the negative physical side effects of using prohibited anabolic steroids. The following classes of anti-estrogenic substances are prohibited:  Aromatase inhibitors including but not limited to, anastrozole, letrozole, aminoglutethimide, exemestane, formestane, testolactone  Selective Estrogen Receptor Modulators (SERMs) including but not limited to,  Other anti-estrogenic substances including but not limited to, clomiphene,  Agents modifying myostatin function(s) including but not limited to, myostatin The LPGA list of prohibited classes and prohibited methods is subject to change by the LPGA
 Metabolic modulators: insulins and peroxisome proliferator activated receptor 7. Diuretics and Other Masking Agents: The LPGA prohibits the use of substances and
methods that alter the integrity and/or validity of urine samples provided during LPGA drug testing. Examples of banned substances are listed below. Masking agents are prohibited. They include but are not limited to: diuretics,
desmopressin, epitestosterone, probenicid, plasma expanders (e.g., glycerol; intravenous
administration of albumin, dextran, dydroxyethyl starch and mannitol) alpha-reductase
inhibitors (e.g. finasteride); and related substances and compounds
Diuretics are prohibited. They include but are not limited to, acetazolamide, bumedanide,
canrenone, chlorthalidone, chlorothiazide, etacrynic acid, furosemide,
hydrochlorothiazide, hydroflumethiazide, indapamide, metolazone, spironolactone, other
thiazides (bendroflumethiazide, hydrochlorothiazide), triamterene; and all related
substances and compounds

8. Non-Approved Substances: Any pharmaceutical substance which is not addressed by
any of the prior sections above and with no current approval by any governmental regulatory health authority for human therapeutic use (e.g., drugs under pre-clinical or clinical development or discontinued) is prohibited at all times. PROHIBITED METHODS
Chemical and Physical Manipulation: The LPGA prohibits the use of substances and
methods that alter the integrity and/or validity of urine samples provided during LPGA drug
testing. Examples of banned methods are catheterization, urine substitution and/or urine
tampering, or modification of renal excretion by the use of diuretics and/or masking agents.
The LPGA list of prohibited classes and prohibited methods is subject to change by the LPGA

Source: http://www.lpga.com/~/media/7f4a920c3a654108aacce6e6494e9f04/123013%20lpga%20prohibited%20substances%20list%202014%20final.pdf


ORDINANCE, SCHEME & SYLLABUS FOR DIPLOMA IN PHARMACY Course Title: Abbreviation: Type of Course: Pattern: Award of the Degree: Diploma will be awarded for those passingin both the years as per rules and regulations. O-D. Ph. 1. DURATION OF THE COURSE : The duration of the course shall be for two academic years, with each academic year spread over a period of not less than

Jakelussa mainitut

LABORATORIOTIEDOTE 12/2006 Jakelussa mainitut PT-VIRTAUSTILAVUUSSPIROMETRIA BRONKODILATAATIOKOKEELLA, 2682 Pt-FVSpirD PT-VIRTAUSTILAVUUSSPIROMETRIA, 2680 Pt-FVSpiro Laboratoriokeskus aloittaa 1.2.2006 virtaustilavuusspirometriatutkimuksen aikuisille ja kouluikäisille lapsille Mäntän laboratoriossa. Spirometriassa esiintyvän obstruktiolöy-döksen, astmaepäilyn ja astmalääkitykse

Copyright © 2010-2014 Internet pdf articles